JNJ vs. ABT
Compare and contrast key facts about Johnson & Johnson (JNJ) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: JNJ or ABT.
Correlation
The correlation between JNJ and ABT is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
JNJ vs. ABT - Performance Comparison
Key characteristics
JNJ:
0.62
ABT:
1.22
JNJ:
0.96
ABT:
1.83
JNJ:
1.13
ABT:
1.23
JNJ:
0.67
ABT:
0.98
JNJ:
1.93
ABT:
6.19
JNJ:
6.14%
ABT:
4.06%
JNJ:
19.11%
ABT:
20.53%
JNJ:
-52.60%
ABT:
-45.66%
JNJ:
-7.83%
ABT:
-6.94%
Fundamentals
JNJ:
$379.48B
ABT:
$227.16B
JNJ:
$8.99
ABT:
$7.64
JNJ:
17.52
ABT:
17.14
JNJ:
1.08
ABT:
4.17
JNJ:
4.25
ABT:
5.36
JNJ:
5.31
ABT:
4.77
JNJ:
$67.44B
ABT:
$31.99B
JNJ:
$46.48B
ABT:
$17.78B
JNJ:
$19.10B
ABT:
$8.53B
Returns By Period
In the year-to-date period, JNJ achieves a 9.37% return, which is significantly lower than ABT's 15.97% return. Over the past 10 years, JNJ has underperformed ABT with an annualized return of 7.46%, while ABT has yielded a comparatively higher 12.55% annualized return.
JNJ
9.37%
-4.10%
-2.08%
9.50%
3.38%
7.46%
ABT
15.97%
3.29%
12.13%
23.51%
8.29%
12.55%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
JNJ vs. ABT — Risk-Adjusted Performance Rank
JNJ
ABT
JNJ vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
JNJ vs. ABT - Dividend Comparison
JNJ's dividend yield for the trailing twelve months is around 3.16%, more than ABT's 1.76% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 3.16% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
ABT Abbott Laboratories | 1.76% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
JNJ vs. ABT - Drawdown Comparison
The maximum JNJ drawdown since its inception was -52.60%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for JNJ and ABT. For additional features, visit the drawdowns tool.
Volatility
JNJ vs. ABT - Volatility Comparison
Johnson & Johnson (JNJ) has a higher volatility of 10.87% compared to Abbott Laboratories (ABT) at 8.89%. This indicates that JNJ's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
JNJ vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Johnson & Johnson and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities